Another batch of Pfizer documents was released by the United States Food and Drug Administration (FDA) on April 1, 2022. The data shows that Pfizer and the FDA knew that people of all ages experienced suppression of immune function for a week after the first dose.
Based on other data compiled from the other ruling classes around the world, we know that immunosuppression and complete immune system degradation is occurring in those who have taken more shots at a much more rapid pace.
The Pfizer trial data showed that natural immunity was as effective as the “vaccine” and that side effects of the jab were more severe in those under 55 years old. And Vaccine-associated enhanced disease (VAED) is recorded as an “important potential risk” and as of February 28, 2021, Pfizer had 138 cases of suspected VAED, 75 of which were severe, resulting in hospitalization, disability, life-threatening consequences, or death.
Further data shows that immune function is being degraded much more quickly in those who take more than one shot. In fact, many ruling classes have simply stopped publishing data because it is showing that the shots are giving people VAIDS. Pfizer’s own trial showed that infection was significantly more common in the vaccine group than in the placebo group — 409 versus 287 — within the first seven days of the jab.
The fact that Pfizer and the U.S. Food and Drug Administration were aware the shot caused immunosuppression is incriminating. But data released by the U.K. government, which compared the unvaccinated to those who have received two doses of the “vaccine” is also rather damaging. The data shows that those “fully vaccinated” are:
- Up to three times more likely to be diagnosed with COVID-19
- Twice more likely to be hospitalized with COVID-19
- Three times more likely to die of COVID-19
The Pfizer documents admit there was a temporary drop in immune function after the first dose, but the real-world data shows an increased and sustained risk of severe infection and death due to COVID among the double jabbed. The documents also suggest VAED or ADE (Antibody-Dependent Enhancement) may indeed be at play later on as well.